期刊文献+

PCR-SSCP技术检测原发性胃腺癌石蜡标本p53第七外显子基因突变的初步研究 被引量:4

The study of p53 gene mutation in exon7 measured by polymerase chain reaction-single strand conformation polymorphsm(PCR-SSCP)and in primary gastric adencarcinomas
下载PDF
导出
摘要 目的 :研究PCR SSCP技术检测原发性胃腺癌石蜡标本中p53第 7外显子基因突变 ,探讨其与肿瘤发展的关系。方法 :应用PCR SSCP(聚合酶链反应 单链构象多态性 )技术检测 37例原发性胃腺癌标本中p53第 7外显子的基因突变 ,同时应用免疫组织化学技术检测p53蛋白的表达。探讨其与肿瘤发展的关系。结果 :37例原发性胃腺癌标本中 ,p53第 7外显子基因突变率为 19% (7/ 37) ,7例发生突变的标本 ,其p53蛋白表达亦呈阳性 ,低分化腺癌突变率高于高、中分化腺癌 (P =0 0 0 0 6 ) ,发生淋巴结转移组突变率高于未发生淋巴结转移组 (P =0 0 0 0 3)。结论 :临床检测胃腺癌原发灶中是否存在p53第 7外显子基因突变 ,有助于识别高度恶性的胃腺癌。 Objective:To investigate the mutation of p53 gene in exon 7 and expression of p53 protein in primary gastric adenocarcinomas, and to study its relation with tumor′s development Methods:The mutation of p53 gene in exon 7 in 37 cases of primary gastric adenocarcinomas were detected by polymerase chain reaction single strand conformation polymorphism(PCR SSCP) and the expression of p53 protein in 37 cases of primary gastric adenocarcinomas was analyzed by immunohistochemistry Results:In 37 cases of primary gastric adenocarcinomas,7cases (19%) showed mutation of p53 gene in exon 7 and positive p53 expression.The mutational rate of p53 gene in exon 7 and positive p53 expression.The mutational rate of poorly differentiated adenocarcinomas was higher than that of well/moderately differentiated ones( P =0 000 6).The mutational rate of those with lymph node metastasis was higer than that of those without lymph node mdtastasis( P =0 000 3).Conclusions:It is useful to recognize highly malignant primary gastric adenocarcinomas by detecting the mutation of p53 gene in exon 7
出处 《肿瘤防治杂志》 2000年第2期120-122,共3页 China Journal of Cancer Prevention and Treatment
关键词 原发性胃腺癌 P53蛋白 基因突变 PCR-SSCP primary gastric adenocarcinomas p53 proten p53 gene mutation PCR SSCP
  • 相关文献

参考文献7

  • 1Waldman V,kinzler KW,Vogelstrin B.P21 isnecessatry for the p53-mediated Gl arrest in human cancer cells[J].CancerRes,1995,55:5187-5190.
  • 2Fritsche M,Haessler C,Brandner G.Induction of nuclear accumulation of thetumorsuppressor protein p53 by DNA-damaging agents[J].Oncogene,1993,8:307-310.
  • 3Tohdo H,Yokozaki H,Haruma K,et al.p53 gene mutations in gaetric adenomas[J].VirchowsArch B-cell Pathol Zncl Mol Pathol,1993,63(3):191-195.
  • 4Levine AJ,Momand J,Finlay CA,et al.The p53 tumor suppressor gene[J].Nature(Lond),1991,351:453-456.
  • 5Orita M,Suzuki Y,Sekiya T,et al.Rapid and sensitive detection of point mutation andDNA polymorphisms using the polymerase chain[J].Proc Natl Acad SciUSA,1989,87:874-878.
  • 6Orita M,Iwahana H,Kanazawa H,et al.Detection of polymorphisms of human DNA bygelelectrophoresis as sing-strand conformation polymorphisms of human DNA bygelelectrophoresis as single-strand conformation polymorphidmd[J].Proc Natl Acad SciUSA,1989,86:2766-2768.
  • 7Spagnolo DV,Turbett GR,Dix B,et al.polymerase chain reation and single-strandcomformation ploymorphism analysis(PCR-SSCP),a nouel means of detecting DNA mutations[J].AdvAnat Pathol,1994,1:61-65. 修回日期:1999-12-18

同被引文献41

  • 1邸立军,刘淑俊,罗健,黄宇光,房文学,周美珍,庞杰.芬太尼透皮贴剂治疗中重度癌痛433例临床观察[J].中国肿瘤临床,2004,31(13):741-743. 被引量:16
  • 2刘锐克,王娟,季新强,刘志民.我国部分地区癌症患者疼痛现况调查[J].中国药物依赖性杂志,2005,14(5):354-359. 被引量:25
  • 3陆宇晗,关珊,马双莲.疼痛教育项目改变癌症患者对疼痛治疗的态度效果评价[J].护士进修杂志,2006,21(8):685-687. 被引量:34
  • 4周俊宜 罗超权.RT-PCR法检测恶性肿瘤细胞端粒酶RNA组分的研究[J].中国肿瘤生物治疗杂志,2000,7(3):202-202.
  • 5Shiying YU, Yan SUN, Haichun ZHANG, et al. Transdermal fentanyl for management of cancer pain in elderly patients in China[J]. Chin German J Clin Oncol, 2004,3(2) : 85.
  • 6Vielvoye-Kerkmeer AP, Mattern C, Uitendaal MP.Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine[J]. J Pain Symptom Manage, 2000,19(3): 185.
  • 7Mohamed Omar Tawfik. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain[J]. Current Medical Research Opinion, 2004,20(3): 259.
  • 8Radbruch L, Sabatowski R, Petzke F, et al. Transderreal fentanyl for the management of cancer pain: a surveyof 1005 patients[J]. Palliative Medicine,2001,15(4):309.
  • 9Donner B, Zene M, Strumpf M, et al. Long--term treatment of cancer pain with transdermal fentanyl[J]. J Pain Symptom Manage, 1998,15(3) : 168.
  • 10Steele RJC, Thompson AM, Hall PA, et al. The p,53 tumour suppressor gene[J].British Journal of Surgery,1998,85:1 460-1 467.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部